A detailed history of Papamarkou Wellner Asset Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Papamarkou Wellner Asset Management Inc. holds 12,940 shares of BMY stock, worth $623,449. This represents 0.5% of its overall portfolio holdings.

Number of Shares
12,940
Holding current value
$623,449
% of portfolio
0.5%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

May 13, 2025

BUY
$51.92 - $59.94 $671,844 - $775,623
12,940 New
12,940 $732 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $102B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Papamarkou Wellner Asset Management Inc. Portfolio

Follow Papamarkou Wellner Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Papamarkou Wellner Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Papamarkou Wellner Asset Management Inc. with notifications on news.